BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Morel A, Bijak M, Niwald M, Miller E, Saluk J. Markers of oxidative/nitrative damage of plasma proteins correlated with EDSS and BDI scores in patients with secondary progressive multiple sclerosis. Redox Rep 2017;22:547-55. [PMID: 28521618 DOI: 10.1080/13510002.2017.1325571] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
Number Citing Articles
1 Tobore TO. On elucidation of the role of mitochondria dysfunction and oxidative stress in multiple sclerosis. Neurol Clin Neurosci 2019;7:305-17. [DOI: 10.1111/ncn3.12335] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
2 Adamczyk B, Koziarska D, Kasperczyk S, Adamczyk-sowa M. Are antioxidant parameters in serum altered in patients with relapsing-remitting multiple sclerosis treated with II-line immunomodulatory therapy? Free Radical Research 2018;52:1083-93. [DOI: 10.1080/10715762.2018.1535176] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
3 Picón-pagès P, Garcia-buendia J, Muñoz FJ. Functions and dysfunctions of nitric oxide in brain. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019;1865:1949-67. [DOI: 10.1016/j.bbadis.2018.11.007] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 15.0] [Reference Citation Analysis]
4 Gopalasingam G, Bartlett CA, McGonigle T, Majimbi M, Warnock A, Ford A, Gough A, Toomey LM, Fitzgerald M. The effects of a combination of ion channel inhibitors on pathology in a model of demyelinating disease. Mult Scler Relat Disord 2019;34:1-8. [PMID: 31202958 DOI: 10.1016/j.msard.2019.06.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
5 Peña-Bautista C, Vento M, Baquero M, Cháfer-Pericás C. Lipid peroxidation in neurodegeneration. Clin Chim Acta 2019;497:178-88. [PMID: 31377127 DOI: 10.1016/j.cca.2019.07.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 8.3] [Reference Citation Analysis]
6 Flauzino T, Simão ANC, de Carvalho Jennings Pereira WL, Alfieri DF, Oliveira SR, Kallaur AP, Lozovoy MAB, Kaimen-maciel DR, Maes M, Reiche EMV. Disability in multiple sclerosis is associated with age and inflammatory, metabolic and oxidative/nitrosative stress biomarkers: results of multivariate and machine learning procedures. Metab Brain Dis 2019;34:1401-13. [DOI: 10.1007/s11011-019-00456-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
7 Liessem-Schmitz A, Teske N, Scheld M, Nyamoya S, Zendedel A, Beyer C, Clarner T, Fragoulis A. Nrf2 Signaling in Sodium Azide-Treated Oligodendrocytes Restores Mitochondrial Functions. J Mol Neurosci 2018;66:229-37. [PMID: 30140996 DOI: 10.1007/s12031-018-1159-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Naseri A, Forghani N, Sadigh-Eteghad S, Shanehbandi D, Asadi M, Nasiri E, Talebi M. Circulatory antioxidant and oxidative stress markers are in correlation with demographics but not cognitive functions in multiple sclerosis patients. Mult Scler Relat Disord 2021;57:103432. [PMID: 34922253 DOI: 10.1016/j.msard.2021.103432] [Reference Citation Analysis]
9 Dziedzic A, Morel A, Miller E, Bijak M, Sliwinski T, Synowiec E, Ceremuga M, Saluk-Bijak J. Oxidative Damage of Blood Platelets Correlates with the Degree of Psychophysical Disability in Secondary Progressive Multiple Sclerosis. Oxid Med Cell Longev 2020;2020:2868014. [PMID: 32655763 DOI: 10.1155/2020/2868014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Tanaka M, Vécsei L. Monitoring the Redox Status in Multiple Sclerosis. Biomedicines 2020;8:E406. [PMID: 33053739 DOI: 10.3390/biomedicines8100406] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
11 Joodi Khanghah O, Nourazarian A, Khaki-Khatibi F, Nikanfar M, Laghousi D, Vatankhah AM, Moharami S. Evaluation of the Diagnostic and Predictive Value of Serum Levels of ANT1, ATG5, and Parkin in Multiple Sclerosis. Clin Neurol Neurosurg 2020;197:106197. [PMID: 32890892 DOI: 10.1016/j.clineuro.2020.106197] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
12 Tobore TO. Towards a comprehensive etiopathogenetic and pathophysiological theory of multiple sclerosis. Int J Neurosci 2020;130:279-300. [PMID: 31588832 DOI: 10.1080/00207454.2019.1677648] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
13 Signorile A, Ferretta A, Ruggieri M, Paolicelli D, Lattanzio P, Trojano M, De Rasmo D. Mitochondria, Oxidative Stress, cAMP Signalling and Apoptosis: A Crossroads in Lymphocytes of Multiple Sclerosis, a Possible Role of Nutraceutics. Antioxidants (Basel) 2020;10:E21. [PMID: 33379309 DOI: 10.3390/antiox10010021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
14 Karabowicz P, Wroński A, Ostrowska H, Waeg G, Zarkovic N, Skrzydlewska E. Reduced Proteasome Activity and Enhanced Autophagy in Blood Cells of Psoriatic Patients. Int J Mol Sci 2020;21:E7608. [PMID: 33066703 DOI: 10.3390/ijms21207608] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]